Publications

Year of Publicationsort ascending Title Faculty Association
2015 Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Frank Porreca, PhD, Todd Vanderah, PhD
2015 Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. Patrick W Mantyh
2015 Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. John M. Streicher, PhD
2015 Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.
2015 Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents. Tally Largent-Milnes, PhD
2015 Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis. Todd Vanderah, PhD
2015 Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. Patrick W Mantyh
2015 The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2015 The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. John M. Streicher, PhD
2015 Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. Frank Porreca, PhD, Todd Vanderah, PhD
2014 Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Frank Porreca, PhD
2014 Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis. Nam Lee, Ph.D.
2014 Three-dimensional printing surgical instruments: are we there yet?
2014 Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons. Tally Largent-Milnes, PhD
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.
2014 Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors. Frank Porreca, PhD
2014 Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. Tally Largent-Milnes, PhD
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2014 Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Roberta Diaz Brinton, Ph.D
2014 Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
2014 External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. Tally Largent-Milnes, PhD
2014 Animal models for opioid addiction drug discovery. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2014 Estrogen: a master regulator of bioenergetic systems in the brain and body. Roberta Diaz Brinton, Ph.D
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, PhD, FAAPS

Pages